Urologix Stock Short Ratio
| ULGXDelisted Stock | USD 0.0001 0.00 0.00% |
Urologix fundamentals help investors to digest information that contributes to Urologix's financial success or failures. It also enables traders to predict the movement of Urologix Pink Sheet. The fundamental analysis module provides a way to measure Urologix's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Urologix pink sheet.
Urologix |
Urologix Company Short Ratio Analysis
Urologix's Short Ratio is typically used by traders and speculators to identify trends in current market sentiment for a particular equity instrument. In its simple terms this ratio shows how many days it will take all current short sellers to cover their positions if the price of a stock begins to rise.
Current Urologix Short Ratio | 1.02 X |
Most of Urologix's fundamental indicators, such as Short Ratio, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Urologix is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
The higher the Short Ratio, the longer it would take to buy back the borrowed shares. In theory, the more short positions are currently outstanding, the faster it will be to cover shorted positions.
CompetitionBased on the latest financial disclosure, Urologix has a Short Ratio of 1.02 times. This is 73.85% lower than that of the Health Care Equipment & Supplies sector and 72.94% lower than that of the Health Care industry. The short ratio for all United States stocks is 74.5% higher than that of the company.
Urologix Short Ratio Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Urologix's direct or indirect competition against its Short Ratio to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of Urologix could also be used in its relative valuation, which is a method of valuing Urologix by comparing valuation metrics of similar companies.Urologix is currently under evaluation in short ratio category among its peers.
Urologix Fundamentals
| Return On Asset | -0.0762 | ||||
| Profit Margin | (0.39) % | ||||
| Operating Margin | (0.07) % | ||||
| Current Valuation | 4.92 M | ||||
| Shares Outstanding | 21.82 M | ||||
| Number Of Shares Shorted | 41.23 K | ||||
| Price To Sales | 0.01 X | ||||
| Revenue | 14.01 M | ||||
| Gross Profit | 5.9 M | ||||
| EBITDA | (373 K) | ||||
| Net Income | (7.61 M) | ||||
| Cash And Equivalents | 492 K | ||||
| Cash Per Share | 0.02 X | ||||
| Total Debt | 4.59 M | ||||
| Debt To Equity | (1.81) % | ||||
| Current Ratio | 0.56 X | ||||
| Book Value Per Share | (0.38) X | ||||
| Cash Flow From Operations | (1.53 M) | ||||
| Short Ratio | 1.02 X | ||||
| Earnings Per Share | (0.22) X | ||||
| Target Price | 1.5 | ||||
| Number Of Employees | 61 | ||||
| Beta | -80.48 | ||||
| Market Capitalization | 82.91 K | ||||
| Total Asset | 5.67 M | ||||
| Retained Earnings | (126.63 M) | ||||
| Working Capital | (612 K) | ||||
| Current Asset | 3.68 M | ||||
| Current Liabilities | 4.29 M | ||||
| Z Score | -28.8 | ||||
| Net Asset | 5.67 M |
About Urologix Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Urologix's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Urologix using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Urologix based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price. You can also try the Correlation Analysis module to reduce portfolio risk simply by holding instruments which are not perfectly correlated.
Other Consideration for investing in Urologix Pink Sheet
If you are still planning to invest in Urologix check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Urologix's history and understand the potential risks before investing.
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal |